Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months (post-treatment)
Awards & highlights
SPARK Trial Summary
The purpose of this study is to determine the best format for delivering a brief behavioral weight loss intervention to young adults 18-25 years of age.
SPARK Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 months (post-treatment)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months (post-treatment)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Weight
SPARK Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Web-basedExperimental Treatment1 Intervention
Participants receive one group face-to-face session followed by 7 web-based lessons, reporting of key behaviors, and feedback on progress.
Group II: Face-to-FaceExperimental Treatment1 Intervention
8 sessions of weekly group behavioral weight loss treatment
Group III: Single SessionActive Control1 Intervention
Single session behavioral weight loss
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Face-to-Face
2008
N/A
~130
Find a Location
Who is running the clinical trial?
The Miriam HospitalLead Sponsor
239 Previous Clinical Trials
37,454 Total Patients Enrolled
75 Trials studying Obesity
15,095 Patients Enrolled for Obesity
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,360 Previous Clinical Trials
4,314,807 Total Patients Enrolled
446 Trials studying Obesity
588,893 Patients Enrolled for Obesity
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger